Cargando…
Human Epidermal Growth Factor Receptor 2 (HER-2/neu)-Directed Therapy for Rare Metastatic Epithelial Tumors with HER-2 Amplification
CASE 1: A 67-year-old Asian female was diagnosed with locally advanced high-grade salivary duct carcinoma in June 2011. Molecular analysis revealed human epidermal growth factor receptor 2 (HER-2) amplification. She received adjuvant therapy with carboplatin/paclitaxel/ trastuzumab and maintenance o...
Autores principales: | Shin, Daniel Sanghoon, Sherry, Timothy, Kallen, Michael E., Wong, Steven, Drakaki, Alexandra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4924467/ https://www.ncbi.nlm.nih.gov/pubmed/27403128 http://dx.doi.org/10.1159/000445827 |
Ejemplares similares
-
HER-2/neu oncogene: what does amplification mean?
por: Pavy, J. J., et al.
Publicado: (1993) -
Breast Cancer and Her-2/Neu
por: Sherwood, Roy
Publicado: (2005) -
HER2/neu-directed therapy for biliary tract cancer
por: Javle, Milind, et al.
Publicado: (2015) -
HER2/neu testing for anti-HER2-based therapies in patients with unresectable and/or metastatic gastric cancer
por: Gómez-Martin, Carlos, et al.
Publicado: (2012) -
TOPOIIα and HER-2/neu overexpression/amplification in Barrett’s oesophagus, dysplasia and adenocarcinoma
por: Rossi, Elisa, et al.
Publicado: (2010)